“We are pleased to announce the release of our new semi-automated CalECG v3 solution for the analysis of ECGs” said CoreLab Partners’ president and chief executive officer, Dr. Mike Woehler. “This new application represents our commitment to advancing technologies in the cardiac safety market sector and complements our established processes in our proprietary WebHeart technology platform” added Woehler.
The well-known AMPS CalECG application, originally designed for the on-screen measurement of ECG signals in the context of pharmaceutical trials, is capable of handling digital ECGs, seamlessly interfacing with several types of formats. The recently introduced version 3 of CalECG includes the new powerful measurement algorithm, Bravo, as well as a diagnostic module assisting the user in the determination of important caliper positions.
